ESR1 and breast carcinoma: In addition, most secretome marker expressions correlate with miRNA cluster expressions in luminal A breast cancer, strengthening our hypothesis that upregulated secretome markers might be potential blood-based biomarkers for ER-positive luminal A breast cancer.